DRKS00023806CompletedNot Applicable
ong-term consequences of COVID-19 for pulmonary and neurocognitive disorders - COVIMMUNE-Clin
Klinik für Neurodegenerative Erkrankungen und GerontopsychiatrieUniversitätsklinikum Bonn0 sites162 target enrollmentStarted: March 16, 2021Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 162
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 25 Years to 75 Years (—)
- Sex
- All
Inclusion Criteria
- •Patient subjects must belong to one of the following: Asymptomatic or severly affected course of COVID-19 (SARS-CoV-2 positive) infection. Both groups must meet the following criteria:
- •- written informed consent of the subject
- •- aged 25 to 75 years
- •- fulfill the criteria for the respective groups of interest; either to the group of remitted COVID-19 infection cases with an asymptomatic couse (i.e., no symptoms other than anosmia and/or ageusia) or to the group of remitted COVID-19 infection cases with a severe course (i.e., requiring hospital stay)
- •- able and willing to participate throughout the study
- •- fluent German language abilities
- •Healthy controls will only be included if they meet all of the following criteria
- •- written informed consent
- •aged 25 to 75 years
- •fluent German language abilities
- •- deny memory concerns
- •- memory performance is above - 1.0 SD od the mean on a cognitive screening of episodiv memory impariment
- •- no substance abuse
- •- no known history of or current diagnosed psychiatric illness
Exclusion Criteria
- •- inability to give informed consent
- •- any condition that clearly interferes with participation in the study
- •- any condition that interferes with the clinical or neuropsychological study procedures
- •- sensory impairment that prevents or significantly interferes with neuropsychological testing
- •- contraindication for MRI
- •- severe or unstable medical condition
- •- current major depressive episode
- •- psychotic disorder, bipolar disorder, substance abuse at present or in the past
- •- known neurodegenerative disorder (Alzheimer's disease, Parkinson's disease, Frontotemporal dementia, Huntington's disease, Amyotrophic Lateral Sclerosis)
- •- vascular dementia, history of stroke, or history of malignant disease
Investigators
Similar Trials
Not yet recruiting
Not Applicable
ong term Effects of Covid on Pulmonary Function and Quality of Life.CTRI/2022/01/039307one
Completed
Not Applicable
Evaluation Of The Chronic Effects Of Covıd-19 Infection On The Respiratory SystemPost-COVID-19 SyndromeCOVID-19NCT06439134Yeditepe University100
Recruiting
Not Applicable
Impact of COVID-19 Pneumonia on Pulmonary Function, Exercise capacity, Mood disorders, and Quality of Life in Long-term Follow UpPost discharge all subjects with SAR-COV-2 (COVID-19 virus) pneumoniaCOVID,pneumonia,exercise capacity,lung function,mood disordersTCTR20210827005Faculty of Medicine, Chiang Mai University72
Completed
Phase 2
Dual MRI for Cardiopulmonary COVID-19 Long HaulersCovid19NCT04828135Bastiaan Driehuys18
Completed
Not Applicable
Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19Covid19SARS-CoV InfectionPulmonary RehabilitationQuality of LifeNCT04649918Schön Klinik Berchtesgadener Land50